Intermittent androgen deprivation: update of cycling characteristics in patients without clinically apparent metastatic prostate cancer

Author： Grossfeld G.D. Chaudhary U.B. Reese D.M. Carroll P.R. Small E.J.

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.58, Iss.2, 2001-08, pp. : 240-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intermittent Androgen Deprivation for Clinically Localized Prostate Cancer: Initial Experience - inhibition by androgens and stimulation by finasteride

By Grossfeld G.D. Small E.J. Carroll P.R.

Urology, Vol. 51, Iss. 1, 1998-01 ,pp. : 137-144

Elsevier

Access to resources Recommend Favorite

Intermittent androgen deprivation after PSA-complete response as a strategy to reduce induction of hormone-resistant prostate cancer

By Oliver R.T.D. Williams G. Paris A.M.I. Blandy J.P.

Urology, Vol. 49, Iss. 1, 1997-01 ,pp. : 79-82

Elsevier

Access to resources Recommend Favorite

Newer approaches to androgen deprivation therapy in prostate cancer

By Pitts W.R.

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 882-882

Elsevier

Access to resources Recommend Favorite

The prognostic importance of prostate specific antigen in the monitorisation of patients undergoing maximum androgen blockade for metastatic prostate cancer

By Kiper Ahmet Yiğitbası Orhan Imamoglu Abdurrahim Tuygun Can Turan Celaleddin

International Urology and Nephrology, Vol. 38, Iss. 3-4, 2006-12 ,pp. : 571-576

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Outcome of Patients with Lymph Node Positive Prostate Cancer after Radical Prostatectomy versus Androgen Deprivation

By Grimm M.-O. Kamphausen S. Hugenschmidt H. Stephan-Odenthal M. Ackermann R. Vogeli T.A.

European Urology, Vol. 41, Iss. 6, 2002-06 ,pp. : 628-634

Elsevier

Access to resources Recommend Favorite